Literature DB >> 8855203

Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.

M Niederberger1, P Ginés, P Y Martin, P Tsai, K Morris, I McMurtry, R W Schrier.   

Abstract

Nitric oxide (NO) is postulated to play a role in the pathogenesis of arterial vasodilation in chronic portal hypertension. This present study investigates the relationship between systemic hemodynamics and the vascular production of NO, as estimated by measuring cyclic guanosine monophosphate (cGMP) in aortic tissue in two models of chronic portal hypertension in the rat: the partial portal vein ligation (PVL) model and CCl4-induced cirrhosis. NOS was also examined by Western blotting in aortic and mesenteric vessels. Sham-operated rats and rats given phenobarbital were used as controls. PVL rats and rats with cirrhosis and ascites showed a typical pattern of a hyperdynamic circulatory state, when compared with their respective controls: mean arterial pressure; PVL: 113 +/- 2 versus 124 +/- 2, P < .01 and cirrhotics: 103 +/- 5 versus 130 +/- 4 mm Hg, P < .01. Cardiac index; PVL: 32 +/- 2 versus 26 +/- 1, P < .01 and cirrhotics: 51 +/- 3 versus 30 +/- 1 mL . min-1 . 100 gm-1, P < .0001. Systemic vascular resistance; PVL: 3.7 +/- 0.1 versus 4.9 +/- 0.2, P < .01 and cirrhotics: 2.1 +/- 0.2 versus 4.4 +/- 0.2 mm Hg . min-1 100 g-1, P < .0001. Aortic cGMP was markedly increased in cirrhotic rats with ascites (728 +/- 83 fmol/ mg protein) as compared with phenobarbital-treated controls (244 +/- 31 fmol/mg, P < .001). This increase was abolished by chronic administration of N(omega)-nitro-L-arginine methyl ester. By contrast, PVL rats had an aortic cGMP concentration similar to sham-operated controls (282 +/- 16 fmol/mg vs. 274 +/- 33 fmol/mg, P = not significant) and significantly lower than that found in cirrhotic rats with ascites. Expression of cirrhotic aortic endothelial nitric oxide synthase (eNOS) was increased but PVL aortic eNOS did not differ from that of controls, whereas the mesenteric eNOS was increased in both PVL and cirrhotic rats as compared with the controls. These results suggest that vascular NO production is higher in cirrhotic rats than in PVL rats. This increased production may contribute to the more marked abnormalities in systemic hemodynamics seen in experimental cirrhosis as compared with PVL.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855203     DOI: 10.1002/hep.510240432

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  16 in total

1.  Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility.

Authors:  R Wiest; S Das; G Cadelina; G Garcia-Tsao; S Milstien; R J Groszmann
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats.

Authors:  Han-Chieh Lin; Ying-Ying Yang; Yi-Tsau Huang; Tzung-Yan Lee; Ming-Chih Hou; Fa-Yauh Lee; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

3.  High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems.

Authors:  J H Henriksen; S Møller; S Schifter; J Abrahamsen; U Becker
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

4.  Pulmonary expression of iNOS and HO-1 protein is upregulated in a rat model of prehepatic portal hypertension.

Authors:  R A Schroeder; C A Ewing; J V Sitzmann; P C Kuo
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

5.  Antioxidant properties of glutamine and its role in VEGF-Akt pathways in portal hypertension gastropathy.

Authors:  Camila Marques; Francielli Licks; Ingrid Zattoni; Beatriz Borges; Luiz Eduardo Rizzo de Souza; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

6.  Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.

Authors:  C M Fernández-Rodriguez; J Prieto; J Quiroga; J M Zozaya; A Andrade; C Rodriguez-Ortigosa
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

7.  Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.

Authors:  Qing-Hong Du; Lin Han; Jun-Jie Jiang; Ya Xu; Wei-Hong Li; Peng-Tao Li; Xin-Yue Wang; Xu Jia
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

8.  Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.

Authors:  P Y Martin; M Ohara; P Gines; D L Xu; J St John; M Niederberger; R W Schrier
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 9.  Nitric oxide and portal hypertension.

Authors:  Juan González-Abraldes; Juan Carlos García-Pagán; Jaime Bosch
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

10.  Renal effects of gentamicin in chronic bile duct ligated rats.

Authors:  Zvi Ackerman; Fanny Karmeli; Galina Pizov; Iddo Ben-Dov; Orit Pappo
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.